Concomitantly, enhanced levels of 4-HNE and decreased expression of HO-1 in the PFC, as well as reduced levels of SOD-1, in the DRG, PFC, and hippocampus of CIS-injected animals have also been demonstrated [18,51,52]. The gene discussed is HMOX1; the disease is in situ carcinoma.